Risk Factors for Electronic Prescription Errors in Pediatric Intensive Care Patients

Gili Kadmon1, Michal Shifrin1, Michal Pinchover2

  • 1Pediatric Intensive Care Unit, Sackler Faculty of Medicine, Schneider Children's Medical Center in Israel, Tel Aviv University, Petach Tikva, Israel.

Insights

Older patients and those with severe conditions are more prone to electronic prescription errors in pediatric intensive care units (PICUs). Understanding these risk factors is key to improving medication safety.

Area of Science:

  • Pediatric intensive care
  • Health informatics
  • Medication safety

Background:

  • Electronic prescribing systems aim to reduce medication errors.
  • Clinical decision support systems (CDSS) are integrated into electronic prescribing.
  • Identifying specific risk factors for errors in pediatric intensive care units (PICUs) is crucial.

Purpose of the Study:

  • To identify risk factors associated with electronic prescription errors.
  • To analyze prescription data from a computerized physician order entry (CPOE) system with CDSS in a PICU.

Main Methods:

  • Retrospective analysis of 6,250 electronic prescriptions.
  • Comparison of error rates across different age groups.
  • Statistical analysis of patient characteristics, disease severity (Pediatric Index of Mortality 2), PICU length of stay, and admission diagnoses.

Main Results:

  • An overall electronic prescription error rate of 1.6% (101 errors).
  • Error rates were significantly higher in patients older than 12 years (2.4%) compared to younger children.
  • Patients with errors had higher disease severity scores, longer PICU stays, more prescriptions, and were more likely to have neurologic diagnoses.

Conclusions:

  • Older patient age is a significant risk factor for electronic prescription errors in the PICU.
  • Increased disease severity, indicated by higher Pediatric Index of Mortality 2 scores, is also linked to higher error rates.
  • These findings highlight the need for targeted interventions to mitigate prescription errors in vulnerable pediatric populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
148
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
173
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
170
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
2.6K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K